Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women's Ischemia Syndrome Evaluation (WISE) ancillary study - Wikidata - wikimedia - TriplyDB

Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women's Ischemia Syndrome Evaluation (WISE) ancillary study

Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women's Ischemia Syndrome Evaluation (WISE) ancillary study

http://www.wikidata.org/entity/Q35149912

about

Coronary microvascular dysfunction, microvascular angina, and treatment strategies.Sex differences in cardiovascular disease - Impact on care and outcomes.Coronary Microvascular Dysfunction, Microvascular Angina, and Management.Sex-specific factors in microvascular angina.Cardiac cyclic nucleotide phosphodiesterases: function, regulation, and therapeutic prospects.Response to pulmonary arterial hypertension drug therapies in patients with pulmonary arterial hypertension and cardiovascular risk factors Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes.Association of aortic stiffness and wave reflections with coronary flow reserve in women without obstructive coronary artery disease: An ancillary study from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluatio Everything you ever wanted to know about phosphodiesterase 5 inhibitors and the heart (but never dared ask): How do they work?Coronary microvascular dysfunction in diabetes mellitus.High-Sensitivity C-Reactive Protein Is a Predictor of Coronary Microvascular Dysfunction in Patients with Ischemic Heart Disease.Are macrophages in tumors good targets for novel therapeutic approaches?

P2860

Q26861073-436C6037-9D62-438E-8895-5F2C6BB2F365 Q30234726-4B106FEF-DD11-49AC-8C62-50632480CB66 Q30277875-DFC2F3C8-CE24-4144-B47A-B696E11B7B8D Q33818831-875FB123-AFDA-459D-A739-E1C988D4893F Q33966155-63FCB1A1-DA9F-4066-A711-AE4E057D27A1 Q34782595-89B8DD37-5AD8-4AAF-9926-ECE7D8DF3E42 Q35859307-ABAC05AA-8321-4EA1-B5F7-02B1C57D9D45 Q36389912-9AFA288B-B3FF-4B04-B351-959A73D8F360 Q38542767-EA01F624-8F23-4D8D-A37A-9953ABA955C1 Q39393549-94282CFB-2CB9-4CF3-97C6-7B061FDF8D52 Q49254663-01141754-47B1-4E12-910D-DE994C675518 Q53665718-AD467271-5FCC-4097-9570-EBB7934FCCF2

P2860

Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women's Ischemia Syndrome Evaluation (WISE) ancillary study

http://www.wikidata.org/entity/Q35149912

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Effect of phosphodiesterase ty ...... luation (WISE) ancillary study

@ast

Effect of phosphodiesterase ty ...... luation (WISE) ancillary study

@en

type

label

Effect of phosphodiesterase ty ...... luation (WISE) ancillary study

@ast

Effect of phosphodiesterase ty ...... luation (WISE) ancillary study

@en

prefLabel

Effect of phosphodiesterase ty ...... luation (WISE) ancillary study

@ast

Effect of phosphodiesterase ty ...... luation (WISE) ancillary study

@en

P1433

Q35149912-E751EDD3-5005-41D5-B19C-507A01BE21A5

P1476

Q35149912-C30A244B-9759-4CCE-8E1F-F521867495AC

P2093

Q35149912-0029302C-216B-4E14-A5DA-1A832A6236B3

Q35149912-6D40B75D-D829-439E-B56F-07209B061C93

Q35149912-7BFBD9FA-B4D0-47F2-BF0F-F328B60A9584

Q35149912-833E8012-0596-4D5C-A766-853BA742EC3D

Q35149912-86D65E31-1158-45D5-A43F-2F2030E5D354

Q35149912-EEDE4AF3-2558-4361-911A-4ECB33591181

P2860

Q35149912-066DD6CE-B56D-4CB0-9B37-37D287BD7FB3

Q35149912-15287668-F737-4CB5-9E52-0044E00500FC

Q35149912-193BEC45-0F69-4538-9A93-8504480A6784

Q35149912-26DE75AB-9285-40FD-9F5B-48285D31D333

Q35149912-33E64C45-E54F-4273-8A79-DDA7C21CD106

Q35149912-34770B00-BC8C-4A47-99AE-59AD98D5A393

Q35149912-37413725-8EDF-4E1A-B0EC-D7964CD69904

Q35149912-3E60C1CC-1D18-4EC0-9836-38ACFE9ECC59

Q35149912-5836E315-014E-4F71-B9D7-82F452A765FB

Q35149912-5DD6B6B9-5889-4566-8A9B-9A6AD124C4BF

P304

Q35149912-F3F0F4C9-EB00-4509-AA34-30DA5849D1B6

P31

Q35149912-3EC29079-33E0-4BDE-BFE1-C5CB7D26BBD6

P356

Q35149912-5FBDB0A6-B1F5-4E1E-AF9E-0628A8EBBC74

P433

Q35149912-AE1858D7-F5DF-40AA-89DC-D8E3B43CBACD

P478

Q35149912-A209F0B7-7F26-4F74-9A6F-89F89B3BEE16

P50

Q35149912-C28820F2-3733-464A-BB09-A85271667BD3

P577

Q35149912-E5E09E7B-A4E3-4329-8EFC-7045C8B9272D

P5875

Q35149912-409B35FC-9681-4E69-8709-328C55380C96

P698

Q35149912-FFE0AAEC-B294-415A-B018-AD0868CF5695

P932

Q35149912-BA21A8D2-CE8F-41C1-A2F8-D0D9CBE63F3A

P356

P1433

Clinical Cardiology

P1476

Effect of phosphodiesterase ty ...... luation (WISE) ancillary study

@en

P2093

Carl J Pepine

http://www.w3.org/2001/XMLSchema#string

Eileen M Handberg

http://www.w3.org/2001/XMLSchema#string

George S Sopko

http://www.w3.org/2001/XMLSchema#string

Rhonda M Cooper-Dehoff

http://www.w3.org/2001/XMLSchema#string

Scott J Denardo

http://www.w3.org/2001/XMLSchema#string

Xuerong Wen

http://www.w3.org/2001/XMLSchema#string

P2860

Coronary artery flow reserve in diabetics with erectile dysfunction using sildenafil

Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory).

The roles of gender, the menopause and hormone replacement on cardiovascular function.

Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.

Overview of gender aspects of cardiac syndrome X.

The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation.

Coronary and systemic hemodynamic effects of sildenafil citrate: from basic science to clinical studies in patients with cardiovascular disease.

Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms.

Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascul

Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies.

P304

483-487

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CLC.20935

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

C Noel Bairey-Merz

P577

2011-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51512551

http://www.w3.org/2001/XMLSchema#string

P698

21780138

http://www.w3.org/2001/XMLSchema#string

P932

3151010

http://www.w3.org/2001/XMLSchema#string